CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

75 hedge funds and large institutions have $84.3M invested in Cascadian Therapeutics, Inc. in 2016 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 17 increasing their positions, 21 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
-5
Holders Change %
-6.25%
% of All Funds
2%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
18
Increased
17
Reduced
21
Closed
22
Calls
$94K
Puts
$55K
Net Calls
+$39K
Net Calls Change
-$446K
Name Holding Trade Value Shares
Change
Shares
Change %
RhumbLine Advisers
76
RhumbLine Advisers
Massachusetts
-$125K -16,409 Closed
New York State Common Retirement Fund
77
New York State Common Retirement Fund
New York
-$107K -14,033 Closed
AllianceBernstein
78
AllianceBernstein
Tennessee
-$93K -12,183 Closed
NFA
79
Nationwide Fund Advisors
Ohio
-$77K -10,169 Closed
AIG
80
American International Group
New York
-$76K -9,986 Closed
VOYA Investment Management
81
VOYA Investment Management
Georgia
-$57K -7,504 Closed
Invesco
82
Invesco
Georgia
-$35K -4,626 Closed
Legal & General Group
83
Legal & General Group
United Kingdom
-$24K -3,199 Closed
Principal Financial Group
84
Principal Financial Group
Iowa
-$20K -2,687 Closed
TC
85
TFS Capital
Pennsylvania
-$17K -2,231 Closed
TSS
86
Two Sigma Securities
New York
-$15K -1,985 Closed
UBS Group
87
UBS Group
Switzerland
-$10K -1,331 Closed
BlackRock
88
BlackRock
New York
-$4K -550 Closed